Latest / Stock Movers / Intel Plummets, Reddit Plunges, Regeneron Climbs on ‘Exceptional’ 3Q Earnings Beat
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio, news. The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg data.
- 0:15Speaker 2: Let's take a look at some of the stocks on
- 0:18Speaker 2: the move today. We can do that with Avalon Purnell.
- 0:20Speaker 2: She's equities reporter for Bloomberg News joining us here in
- 0:23Speaker 2: our studio. Avalon, what are you looking at?
- 0:25Speaker 3: Have to start off with Intel, that's ticker INTC, currently
- 0:28Speaker 3: falling 28% most intraday since 2024, though earlier it touched
- 0:34Speaker 3: most intraday on record when it hit 30% lower. And
- 0:37Speaker 3: that's after the chipmaker's outlook was much weaker than expected
- 0:40Speaker 3: and also spurred a downgrade at Bank of America to
- 0:43Speaker 3: neutral as well. Interestingly, though, this is because of makers
- 0:47Speaker 3: of laptops and desktops continue to struggle with those memory shortages.
- 0:52Speaker 3: That's cutting into PC shipments and really hurting demand for
- 0:55Speaker 3: Intel's key customers. And management highlighting that they actually expected
- 0:59Speaker 3: that their company's data center unit could have actually done
- 1:01Speaker 3: a lot better had there not been supply shortages. So
- 1:04Speaker 3: definitely something that will be kind of interesting to continue following.
- 1:08Speaker 2: As a former director of research, I just want to
- 1:09Speaker 2: make it clear. If you downgrade the stock. You downgrade
- 1:13Speaker 2: it at the level which it opens trading today. So
- 1:15Speaker 2: he doesn't get the downgrade at $ 91 a share. He
- 1:18Speaker 2: gets it at $ 66.
- 1:18Speaker 1: Okay.
- 1:19Speaker 2: Where does it go from there? Yeah.
- 1:21Speaker 1: Oh, I didn't realize that. You're darn right you do. Yep. Ah, okay.
- 1:25Speaker 2: That's why a downgrade after an earnings print is pointless.
- 1:28Speaker 2: It's kind of lame.
- 1:29Speaker 1: Okay. I should wait a few days. I know.
- 1:31Speaker 2: Seriously.
- 1:31Speaker 1: Next up for you. Next up, Reddit.
- 1:33Speaker 3: Ticker RDDT. That one is sinking 27% most intraday on record.
- 1:40Speaker 3: And that's after the online forum firm also reported weaker
- 1:42Speaker 3: than expected daily active users for their platform in the
- 1:46Speaker 3: third quarter. They also forecast fourth quarter revenue that fell
- 1:49Speaker 3: short of Wall Street's expectations. Also have another downgrade for
- 1:52Speaker 3: you there at KeyBank, which noted that search traffic is
- 1:55Speaker 3: continuing to be a larger headwind than expected. which is
- 1:58Speaker 3: kind of similar to what we saw earlier this week
- 2:00Speaker 3: from Alphabet, which also reported less ad revenue than expected
- 2:03Speaker 3: because of how AI is really changing some user behavior.
- 2:07Speaker 2: Did I tell you I use Reddit?
- 2:09Speaker 1: No. See?
- 2:10Speaker 2: Yep.
- 2:10Speaker 1: How about that?
- 2:11Speaker 3: You have the app on your phone.
- 2:13Speaker 1: I have the app on my phone. You did not
- 2:14Speaker 1: set up a login yet.
- 2:15Speaker 2: No.
- 2:15Speaker 3: Wait, you're joking.
- 2:16Speaker 1: I do have it.
- 2:17Speaker 2: It's on the phone. What I found is it's just gossip, basically.
- 2:21Speaker 1: It is. Okay. People like gossip, Paul.
- 2:24Speaker 2: Sometimes it is. I'll type in a topic that's interesting
- 2:27Speaker 2: and see what all the.
- 2:28Speaker 1: Hoyt lawyers say.
- 2:28Speaker 3: So you have not contributed is what you're saying?
- 2:31Speaker 1: No.
- 2:32Speaker 2: No.
- 2:32Speaker 1: No, please. He has no plans to.
- 2:33Speaker 2: I have no plan to. But there are people, the
- 2:35Speaker 2: young folks are all out there doing it. So that's
- 2:37Speaker 2: a good thing. One more for us.
- 2:39Speaker 3: Yes, Regeneron, that's ticker R-E-G-N. I do have a bright
- 2:42Speaker 3: spot here. It's jumping 12% most intraday now since 2022.
- 2:48Speaker 3: And that's after the biotech reported revenue and adjusted profit
- 2:51Speaker 3: that surpassed Wall Street's expectations. Learink calling the results exceptional,
- 2:55Speaker 3: noting that they were mostly driven by really great drug sales,
- 2:59Speaker 3: especially for its blockbuster collaboration with Sanofi, which is Dupixent.
- 3:03Speaker 3: And so definitely something that we're gonna be keeping an
- 3:05Speaker 3: eye on, especially as they continue to expand this collaboration
- 3:08Speaker 3: as well, what could be down the pipeline later on
- 3:11Speaker 3: for their drug sales in the future.
- 3:14Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:18Speaker 1: us throughout the day for the latest roundup of companies
- 3:20Speaker 1: making news on Wall Street. And for the latest market-moving headlines,
- 3:25Speaker 1: listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg.com,
- 3:29Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
- 3:32Speaker 1: Business app.